Cml Healthcare Inc news

   Watch this stock
Showing stories 1 - 10 of about 19   

Articles published

CLC 0.0000
price chart
Intratumor Heterogeneity (aka, Things Have Many Parts)
After all, now that we know that it's possible to target the abnormal cellular mechanisms triggered by genetic mutations with laboratory-synthesized chemicals (Gleevec for CML, the recently approved Xalkori (generic name, crizotinib) for lung cancer ...
Related articles »  
NICE backs Tasigna and Glivec for CML, but turns down Sprycel
NICE's latest guidance reaffirms its earlier opinion on Novartis' Glivec (imatinib) in CML, supporting use of a 400mg dose of the drug on the National Health Service in England and Wales, and also recommends the use of the company's follow-up Tasigna ...
Related articles »  
SBMT announces 2012 recipients of Pioneers in Medicine, Technology and ...
Today, the Society for Brain Mapping & Therapeutics announced the 2012 recipients of the organization's prestigious Pioneers in Medicine, Technology, and Healthcare Policy Awards. The Society will honor each recipient at the Brain Mapping Foundation's ...
Related articles »  
Standard Bank's Full-Year Profit Climbs 22% After Job Cuts to Lower Costs
... they're the only bank that has acted contra-cyclically and that they've continued lending at this point in the cycle at better margins and better security values,� said Neville Chester, a fund manager at Cape Town-based Coronation Fund Managers Ltd ...
Related articles »  
Subprime Revives in U.K. as Apollo Collects on Debt: Mortgages
... ballooned to about 25 billion pounds in 2006 from 1 billion pounds a decade earlier as home prices rose. The CML estimates that in 2007, mortgages to credit adverse people accounted for as much as six percent of gross mortgage advances.
Related articles »  
New Inhibitors of a Cancer-Causing Protein May Lead to Targeted Therapeutics
The hyperactivity of the Abl kinase is the most common cause of chronic myelogenic leukemia (CML). Imatinab is routinely used to treat CML. Since Imatinib's Food and Drug Administration-approval in 2001, deaths related to CML have dropped significantly.
Related articles »  
Thumbs down for Merck & Co and Ariad sarcoma drug Taltorvic from FDA advisory
The US Food and Drug Administration Oncologic Drugs Advisory Committee (ODAC) yesterday voted by 13 to one against approving Taltorvic (ridaforolimus), from US drug giant Merck & Co (NYSE: MRK) and partner Ariad Pharmaceuticals (Nasdaq: ARIA), ...
Related articles »  
GOP candidate gives pitch at wrong convention
Republican congressional candidate Dan Dolan of Muscatine arrived early at the Monroe County Courthouse for the Republican convention being held Saturday in Albia, Iowa.
Related articles »  
Police officer accused of stealing from mother-in-law
Brown, who suffers from mental health issues, lived at Rock Island Healthcare & Rehabilitation Center when the DeCaps established an account for her at an American Bank branch in Davenport in January 2010 with Brown's money, records show.
Newest iPad makes its Quad-Cities debut
Kristy Welker, communications representative for Target Corp., said the retailer is expecting a high demand and turnout for the tablet's launch.
Related articles »